Former FCA CEO Sergio Marchionne on Life Support, Report Says

Fiat Chrysler announced late last week that Sergio Marchionne would be unable to return to his post as CEO. Without elaborating further, the company said that complications he suffered while recovering from surgery had worsened significantly. Now, a new report is claiming that Marchionne had undergone an operation for an invasive shoulder sarcoma and suffered an embolism.

Citing anonymous sources, Italian business website Lettera43 said Marchionne had been diagnosed “long ago” with the malignant form of cancer. The report also said he didn’t inform Fiat Chrysler Chairman John Elkann about the severity of his illness. He was having “severe shoulder pain that made arm movements difficult,” according to a translation of the Italian report cited by Automotive News. Sources told the latter publication that Marchionne also had a chronic thyroid condition that he had been taking medications to treat. Before his surgery at the University of Zurich, which took place in late June, Marchionne shared some of the doubts he had about how effective it would prove, Lettera43 said.

The cerebral embolism that he suffered during the procedure sent him into a coma, Lettera43 says. He has reportedly suffered irreversible damage to his brain function. Doctors say he has no chance of recovery, the report claims, and that they are relying on machines to keep him alive.

Mike Manley, head of Jeep and Ram, has taken over to lead Fiat Chrysler. Marchionne wasn’t expected to retire until next year.

FCA declined to comment to Motor Trend.

We hope the situation isn’t as dire as the report makes it out to be, but whatever the case, our thoughts are with the Marchionne family in this difficult time. We’ll update this post as more details become available.

Source: Lettera43 via Automotive News (Subscription required)

The post Former FCA CEO Sergio Marchionne on Life Support, Report Says appeared first on Motor Trend.



from Motor Trend https://ift.tt/2LyFHtq

Aucun commentaire:

Enregistrer un commentaire